Retained Earnings - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Maat Pharma SA
Retained Earnings Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Retained Earnings
-€18.1m
CAGR 3-Years
-57%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Retained Earnings
-€448.6m
CAGR 3-Years
-19%
CAGR 5-Years
-20%
CAGR 10-Years
-20%
Nanobiotix SA
PAR:NANO
Retained Earnings
-€316.5m
CAGR 3-Years
-19%
CAGR 5-Years
-24%
CAGR 10-Years
-38%
Innate Pharma SA
PAR:IPH
Retained Earnings
-€361.3m
CAGR 3-Years
-14%
CAGR 5-Years
-24%
CAGR 10-Years
-14%
Genfit SA
NASDAQ:GNFT
Retained Earnings
-€389.8m
CAGR 3-Years
1%
CAGR 5-Years
-10%
CAGR 10-Years
-27%
Eurobio Scientific SA
PAR:ALERS
Retained Earnings
€137.9m
CAGR 3-Years
30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Retained Earnings?
Retained Earnings
-18.1m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Retained Earnings amounts to -18.1m EUR.

What is Maat Pharma SA's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-10%

Over the last year, the Retained Earnings growth was -45%. The average annual Retained Earnings growth rates for Maat Pharma SA have been -57% over the past three years , -10% over the past five years .

Back to Top